Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tempest Therapeutics, Inc. | 3,820,571 | reported | 07 Mar 2014 | tx 7+3,410,425−4,818,181 |
| Salarius Pharmaceuticals, Inc. | 844,627 | reported | 20 Dec 2018 | tx 90+3,138,503−16,483,917 |
| Sirtris Pharmaceuticals, Inc. | 744,053 | reported | 29 May 2008 | tx 123+784,630−252,177 |
| Verastem, Inc. | 665,224 | reported | 30 Jun 2015 | tx 82+5,027,796−8,045,938 |
| ALNYLAM PHARMACEUTICALS, INC. | 0 | reported | 03 Jun 2004 | tx 15+2,823,027−4,770,008 |
| TScan Therapeutics, Inc. | 0 | reported | 20 Jul 2021 | tx 5+1,278,838−1,145,505 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jul 2021 | CONVERSION | TScan Therapeutics, Inc. | 1,145,505 | — | |
| 20 Jul 2021 | PURCHASE | TScan Therapeutics, Inc. | 133,333 | 15.00 USD | first after silence |
| 20 Jul 2021 | CONVERSION | TScan Therapeutics, Inc. | 641,848 | — | deriv |
| 20 Jul 2021 | CONVERSION | TScan Therapeutics, Inc. | 171,063 | — | deriv |
| 20 Jul 2021 | CONVERSION | TScan Therapeutics, Inc. | 332,594 | — | deriv |
| 20 Dec 2018 | GIFT | Salarius Pharmaceuticals, Inc. | 2,200,000 | 0.00 USD | |
| 06 Nov 2018 | GIFT | Salarius Pharmaceuticals, Inc. | 858,300 | 0.00 USD | |
| 16 Oct 2018 | SALE | Salarius Pharmaceuticals, Inc. | 3,212,861 | 0.92 USD | anomaly |
| 26 Jul 2017 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 08 Nov 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 7,000 | 7.31 USD | |
| 07 Nov 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 8,870 | 5.70 USD | |
| 23 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 2,700 | 11.28 USD | |
| 22 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 2,900 | 11.03 USD | |
| 21 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 2,800 | 11.07 USD | |
| 17 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 3,000 | 10.98 USD | |
| 20 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 3,000 | 11.37 USD | |
| 16 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 2,900 | 11.10 USD | |
| 15 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 2,900 | 11.24 USD | |
| 13 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 2,900 | 11.90 USD | |
| 14 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 3,000 | 11.19 USD | |
| 09 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 3,000 | 12.04 USD | |
| 10 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 3,000 | 11.83 USD | |
| 07 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 3,000 | 12.26 USD | |
| 08 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 2,900 | 12.24 USD | |
| 06 Jun 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 3,000 | 12.33 USD |
2 purchases reported after at least 12 months of silence — most recent on 20 Jul 2021.